We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+13.29%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$47.2B
AUM Growth
+$8.08B
(+21%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
35.89%
Holding
5,834
New
1,032
Increased
1,743
Reduced
1,554
Closed
961
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$376M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$115M |
| 3 |
Lam Research
LRCX
|
+$51.4M |
| 4 |
Crown Castle
CCI
|
+$45.4M |
| 5 |
Wyndham Hotels & Resorts
WH
|
+$43.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$59.4M |
| 2 |
VMW
VMware, Inc
VMW
|
+$57.2M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$52.6M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$48M |
| 5 |
Microsoft
MSFT
|
+$43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.27% |
| 2 | Financials | 2.09% |
| 3 | Healthcare | 1.72% |
| 4 | Consumer Discretionary | 1.48% |
| 5 | Industrials | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LYRA
4076
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $78.6K | ﹤0.01% |
+300
| New | +$54.3K |
|
4077
Agilon Health
AGL
$1.53B
| $78.6K | ﹤0.01% |
+250
| New | +$90.5K |
|
|
PHT
4078
DELISTED
Pioneer High Income Fund
PHT
| $78.5K | ﹤0.01% |
+10,974
| New | +$76.2K |
|
4079
CALL
Viridian Therapeutics
VRDN
$2.09B
| $78.4K | ﹤0.01% |
3,600
-300
| -8% | -$4.74K |
|
4080
PUT
PAR Technology
PAR
$699M
| $78.4K | ﹤0.01% |
1,800
-3,100
| -63% | -$116K |
|
4081
CALL
Crinetics Pharmaceuticals
CRNX
$8.84B
| $78.3K | ﹤0.01% |
+2,200
| New | +$67.5K |
|
4082
CALL
Telus
TU
$14.9B
| $78.3K | ﹤0.01% |
4,400
-1,800
| -29% | -$31.1K |
|
4083
Woodward
WWD
$21.5B
| $78.1K | ﹤0.01% |
+574
| New | +$75K |
|
4084
PUT
NETGEAR
NTGR
$648M
| $77.3K | ﹤0.01% |
+5,300
| New | +$68.6K |
|
|
RCM
4085
CALL
DELISTED
R1 RCM Inc. Common Stock
RCM
| $77.2K | ﹤0.01% |
+7,300
| New | +$82.8K |
|
|
HBI
4086
CALL
DELISTED
Hanesbrands
HBI
| $77.2K | ﹤0.01% |
17,300
-11,200
| -39% | -$45.6K |
|
4087
CALL
Hawaiian Electric Industries
HE
$2.23B
| $76.6K | ﹤0.01% |
5,400
-900
| -14% | -$11.7K |
|
4088
CALL
Mativ Holdings
MATV
$481M
| $76.5K | ﹤0.01% |
+5,000
| New | +$67.5K |
|
4089
CALL
Arcus Biosciences
RCUS
$3.55B
| $76.4K | ﹤0.01% |
4,000
-100
| -2% | -$1.6K |
|
4090
IPG Photonics
IPGP
$3.61B
| $76K | ﹤0.01% |
700
-595
| -46% | -$57.6K |
|
4091
CALL
CryoPort
CYRX
$761M
| $75.9K | ﹤0.01% |
+4,900
| New | +$64K |
|
4092
PUT
Bread Financial
BFH
$4.37B
| $75.8K | ﹤0.01% |
+2,300
| New | +$68.7K |
|
|
PENG
4093
CALL
Penguin Solutions Inc
PENG
$2.7B
| $75.7K | ﹤0.01% |
4,000
+400
| +11% | +$6.92K |
|
4094
CALL
Ascendis Pharma A/S
ASND
$16B
| $75.6K | ﹤0.01% |
600
-1,300
| -68% | -$130K |
|
4095
CALL
Avantor
AVTR
$9.32B
| $75.3K | ﹤0.01% |
3,300
-24,300
| -88% | -$498K |
|
4096
PUT
MillerKnoll
MLKN
$1.53B
| $74.7K | ﹤0.01% |
2,800
-3,100
| -53% | -$79.1K |
|
4097
PUT
CenterPoint Energy
CNP
$27.7B
| $74.3K | ﹤0.01% |
2,600
+2,500
| +2,500% | +$69.5K |
|
4098
Bit Digital
BTBT
$463M
| $74.1K | ﹤0.01% |
17,520
-31,667
| -64% | -$82.7K |
|
4099
PUT
Regal Rexnord
RRX
$13.7B
| $74K | ﹤0.01% |
+500
| New | +$63.1K |
|
4100
PUT
First Majestic Silver
AG
$7.41B
| $73.8K | ﹤0.01% |
12,000
+4,000
| +50% | +$22K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Walleye Capital held 5,834 positions worth $47.2B, up 21% from $39.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Walleye Capital deployed $2.33B of net new capital in Q4 2023, opening 1,032 new positions and adding to 1,743 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 2.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $59.4M trimmed.
- Walleye Capital's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
- Walleye Capital added most to Lam Research in Q4 2023, an estimated $51.4M increase.
- Walleye Capital's biggest Q4 2023 reduction was Advanced Micro Devices, cutting an estimated $59.4M.
- Walleye Capital fully exited VMware, Inc in Q4 2023, selling an estimated $57.2M.
- Walleye Capital's ten largest holdings make up 36% of its $47.2B portfolio in Q4 2023.
- Walleye Capital opened 1,032 new positions and closed 961 in Q4 2023.
- Walleye Capital's portfolio value rose 21% quarter-over-quarter to $47.2B.
Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.